Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 5 (abbreviated H3P5, alias p12) is classified as a **pseudogene** belonging to the histone H3 family[1][5]. Pseudogenes are DNA sequences similar to known genes but are generally non-functional due to mutations that prevent normal gene expression or protein production. H3P5 does not encode a functional histone protein or have established biological or therapeutic relevance[1][5]. While histone H3 proteins play a fundamental role in chromatin structure and gene regulation, pseudogenes like H3P5 do not contribute to these functions[2][4][5]. There is no evidence of involvement of H3P5 in disease pathogenesis, no known drug interactions, no biomarker function, and no safety concerns reported for this locus[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 5 (H3P5).